Navigation Links
Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance
Date:2/26/2015

MILFORD, Mass., Feb. 26, 2015 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of virus infections, today announced that Jonathan P. Freve, CPA, has been appointed Vice President of Finance, a newly created role.  Mr. Freve will be responsible for financial and administrative activities, including financial planning and reporting, accounting and risk management. He reports to Douglas J. Jensen, President and CEO.

Mr. Freve joins the Company with more than 16 years of progressive experience in the life science and technology industries ranging from venture-backed start-ups to publicly traded companies. Prior to joining Spring Bank Pharmaceuticals, he served as the Senior Director of Finance of Santaris Pharma A/S, which was acquired by F. Hoffmann-La Roche Ltd.  Previously, Mr. Freve held controller positions at  two international public companies.  Mr. Freve began his career at the Financial Accounting Standards Board (FASB) and PricewaterhouseCoopers, where he worked in the audit and transaction services practices.  Over his career, Mr. Freve has supported and worked on numerous successful initial public offerings, secondary offerings, mergers and acquisitions, ERP implementations and a variety of complex accounting matters.  Mr. Freve is a certified public accountant in Massachusetts and holds a Bachelor's degree in Business Administration from the University of Massachusetts Amherst.

Douglas J. Jensen, President and CEO, stated, "I am very pleased to welcome Jon Freve to Spring Bank Pharmaceuticals.  Jon is an accomplished financial professional with a proven track record of success and excellent leadership skills. With his strong background in accounting and finance for life sciences and technology companies, I'm very confident that Jon will make many valuable contributions to Spring Bank's continued progress."  

 "I am excited about the unique opportunity to work for Spring Bank Pharmaceuticals, an emerging biotechnology company that I believe has tremendous potential," said Mr. Freve. "I look forward to working with Doug and the team and leading the finance and accounting functions during this period of growth."

About Spring Bank Pharmaceuticals

Spring Bank Pharmaceuticals is a clinical stage biopharmaceutical company. Based on its proprietary SMNH chemistry platform, Spring Bank is developing a pipeline of products representing a new class of pharmaceuticals with a wide range of applications. These rationally designed molecules combine the selectivity of naturally occurring nucleotides with the drug- like properties of classical pharmaceuticals. The SMNHs have the properties of oral delivery, good pharmacokinetic profile, low side effects and ease of manufacture. The Company's most advanced clinical candidate, SB 9200, is a potential breakthrough drug for the treatment for HBV and other viral diseases. SB 9200 has a novel mechanism of action that involves modulation of the host immune response in the presence of viral infection.

Contact:
Douglas J. Jensen
President and Chief Executive Officer
(508) 473-5993 x105

 


'/>"/>
SOURCE Spring Bank Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
2. Aptuit Names Jonathan Goldman As CEO
3. Chief Financial Officer Jonathan M. Peacock to Leave Amgen; Company Appoints Michael A. Kelly Acting Chief Financial Officer
4. Former NBA star Jonathan Bender joins ISGP, a green technology company
5. AMC Health Names Innovative Physician Leader Jonathan Leviss Medical Director
6. Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
7. Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers
8. Specialty Operations Solutions joins The WorkingBuildings Companies
9. Dr. M. Fatih Yanik joins Intellimedix
10. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
11. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... ... adults living with memory impairment, has announced the Best Memory Care Facilities in ... access to experts, facility features and amenities. , According to the ...
(Date:1/3/2020)... HILLS, Calif. (PRWEB) , ... January 02, 2020 , ... ... Dr. Matt Nejad , leading expert and educator in cosmetic and biomimetic dentistry, ... Institute with a new website at http://www.nejadinstitute.com . , Dentists from around ...
(Date:1/3/2020)... , ... January 03, 2020 , ... ... medicinal attributes to transform the health of their patients. Although many medical professionals ... prescription is not needed. Smart shoppers are finding this product online. , In ...
Breaking Medicine Technology:
(Date:1/10/2020)... (PRWEB) , ... January 10, 2020 , ... ... the complexities of autoimmune conditions, HMP, a leading healthcare event and education company, ... help improve patient care. , The Autoimmune Learning Network serves as a robust ...
(Date:1/10/2020)... (PRWEB) , ... January 10, 2020 , ... ... today announced that its Certified Pediatric Emergency Nurse (CPEN) specialty nursing ... (ABSNC). , The CPEN is a national board certification earned by registered ...
(Date:1/8/2020)... Va. (PRWEB) , ... January 09, 2020 , ... ... 30 Pharma Companies, An FDAnews/CenterWatch Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. ... (RWE) and real world data (RWD) to generate evidence and identify gaps and ...
(Date:1/7/2020)... ... January 07, 2020 , ... Midmark Corp., a ... six trends that will significantly impact the point of care ecosystem, where the ... between a provider and patient is the most important aspect of the healthcare ...
(Date:1/7/2020)... ... ... Twenty-six people, all but one who live with Young Onset Parkinson’s Disease (YOPD) ... 6th World Parkinson Congress. The participants, representing 11 countries , will each host ... in 2020. The group aims to raise at least $50,000 for travel grants to ...
Breaking Medicine News(10 mins):